Fiore Michael Henry 4

What Happened Michael Fiore, EVP and Chief Commercial Officer of Healthequity (HQY), sold 3,142 shares in an open-market transaction on May 29, 2026 at $95.00 per share, for total proceeds of $298,490. This was a sale (not a purchase); such sales are often routine and may be pre-planned rather than a direct signal about the company.

Key Details

• Transaction date: May 29, 2026; Price: $95.00 per share; Shares sold: 3,142; Proceeds: $298,490.
• Filing date / accession: Form 4 filed June 2, 2026 (four days after the trade). Form 4s are normally due within two business days, so this filing appears later than typical.
• Shares owned after transaction: Not specified in the provided filing summary.
• Footnote: The sale was executed under a Rule 10b5-1 trading plan adopted by Mr. Fiore on October 14, 2025 (pre-established plan for scheduled trades).

Context

• A 10b5-1 plan generally indicates the trade was pre-planned and executed according to the plan’s parameters, which can reduce the likelihood the sale was based on undisclosed, material information.
• This was a direct sale of shares (code S)—no options exercise, gift, or tax-withholding event reported in the provided data.

For investors: sales by executives are common and can be part of planned diversification or liquidity needs; consider this data point alongside other insider activity and company fundamentals.